arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2510.21708stat.ME
收藏

复制研究和双试验规则的最优加权检验

Optimal weighted tests for replication studies and the two-trials rule

MRC Biostatistics Unit, University of Cambridge(剑桥大学生物统计单元);University of Regensburg(雷根斯堡大学)

David S. Robertson, Thomas Jaki

AI总结:

本文提出基于原始研究结果的最优加权Bonferroni程序用于复制研究,以最大化析取功效,并证明其能显著提升功效且对效应量变化稳健。

摘要:

科学研究中的复制研究是确保实验结果可靠性和完整性的重要组成部分。在临床试验的背景下,复制的概念已通过“双试验”规则被正式化,即要求两项关键研究均显示阳性结果,药物才能获批。在同时检验多个假设的实验中,许多情况下还需要控制总体家族错误率(FWER)。著名的Bonferroni程序可控制FWER,其自然扩展是引入权重以反映假设的先验重要性或最大化实验总体功效的某种度量。在本文中,我们考虑使用最优加权Bonferroni程序分析复制研究,其中权重基于被复制的原始研究的结果,最优性标准为最大化试验的析取功效(即拒绝至少一个非零假设的功效)。我们表明,使用所提出的程序可显著提高复制研究的析取功效,并且对两项研究之间效应量的变化具有稳健性。

英文摘要:

Replication studies for scientific research are an important part of ensuring the reliability and integrity of experimental findings. In the context of clinical trials, the concept of replication has been formalised by the 'two-trials' rule, where two pivotal studies are required to show positive results before a drug can be approved. In experiments testing multiple hypotheses simultaneously, control of the overall familywise error rate (FWER) is additionally required in many contexts. The well-known Bonferroni procedure controls the FWER, and a natural extension is to introduce weights into this procedure to reflect the a-priori importance of hypotheses or to maximise some measure of the overall power of the experiment. In this paper, we consider analysing a replication study using an optimal weighted Bonferroni procedure, with the weights based on the results of the original study that is being replicated and the optimality criterion being to maximise the disjunctive power of the trial (the power to reject at least one non-null hypothesis). We show that using the proposed procedure can lead to a substantial increase in the disjunctive power of the replication study, and is robust to changes in the effect sizes between the two studies.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑